
Melanocortin & dermal
Melanotan I (MT-1)
Selective MC1R agonist (afamelanotide)
Overview
Selective MC1R agonist (afamelanotide)
A linear α-MSH analog, afamelanotide, with preferential binding at MC1R relative to other melanocortin receptor subtypes. Supplied lyophilized for in-vitro study of MC1R-selective melanocortin signaling.
- Fill: 10 mg / vial
- Pack: 1 vial · 10 mg total
- Purity: ≥99%
For in-vitro laboratory research use only. Not for human or animal consumption, medical, diagnostic or therapeutic use.
Receptor pharmacology
Selective MC1R agonism stimulates eumelanin production and provides photoprotective effects in dermal tissue, with minimal MC4R activity (less nausea/libido effect than MT-2).
Laboratory handling
Research use disclaimer
Sacred Peptides does not provide dosing recommendations for human use. Melanotan I (MT-1) is supplied for in-vitro laboratory research only. Any concentration ranges referenced on this page or in cited studies describe the parameters used in that research and are not instructions.
- Not a drug. Not approved by Health Canada or the FDA for human use.
- Not intended to diagnose, treat, cure, or prevent any disease.
- Not for use in humans, pregnant or nursing individuals, or animals outside a controlled research setting.
- Handling, storage, and disposal are the responsibility of a qualified researcher.